Tilray Brands' stock rises following the expansion of its non-alcoholic craft beer brand and the launch of a new medical ...
Medical announces the introduction of Tilray Craft, a new brand extension of the Tilray Medical brand within its medical cannabis ...
In a report released today, Michael Lavery from Piper Sandler maintained a Hold rating on Tilray (TLRY – Research Report), with a price target ...
There are two potential catalysts that could be especially important for Tilray on this front. Germany, which already has a thriving medical cannabis market, legalized adult-use marijuana in 2024 ...
Tilray Medical is also expanding its medical cannabis extract portfolio in Germany with new offerings to meet growing demand.
Global Leader in Medical Cannabis Launches New Cannabis Extract Products and Formulations NEUMÜNSTER, Germany, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, ...
Tilray Brands (NasdaqGS:TLRY) Sees 19% Decline As Settlement In Lawsuit Weighs On Investor Sentiment
Despite Tilray's efforts to innovate and expand, such as launching the Good Supply's Monsters product line and expanding its medical cannabis portfolio in Germany, the company's share price struggled.
NEUMÜNSTER, Germany, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), and a global leader in medical cannabis, empowering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback